French hospital staff antibody study reveals infection patterns
NCT ID NCT04481529
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested over 1,500 hospital workers in four French hospitals for COVID-19 antibodies to see how many had been infected. Researchers compared infection rates among staff in COVID-19 units, other care areas, and non-care roles, and across regions with different outbreak intensities. The goal was to understand exposure risks and help protect healthcare workers in future waves.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help hospitals better understand which staff are at highest risk of infection and improve protection strategies.
- What could go wrong
- This is an observational study, not a treatment trial. Results may not apply to other regions or time periods, and antibody tests can miss past infections.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,576 people
The number who actually took part.
- Started
-
Jul 2020
- Finished
-
Oct 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Hospital staff
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospital staff from Argenteuil, Belfort, Dijon and Limoges hospitals. * Age ≥ 18 years old * Participation agreement Exclusion Criteria: * Protected persons * Refusal of participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Infection viral are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Argenteuil - Service de Réanimation
Argenteuil, Argenteuil, 95107, France
-
CHU Dijon - Serve de Réanimation
Dijon, Dijon, 21079, France
-
CHU de Limoges
Limoges, France
-
Ch Belfort
Belfort, 90000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a tweaked bird flu shot build stronger immunity?
- Scientists collect samples from COVID-19 patients to unlock virus secrets
- New blood test aims to detect hidden infections in vulnerable patients
- New blood test could spot dangerous infections in feverish kids faster
- New biosensors aim to diagnose infections in minutes
- Can a simple blood test predict which COVID patients will get worse?